Shengfang Ge (S Ge)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Catheter Ablation

Natural Killer Cells

Top Venues

OncoTargets and therapy

Science advances

Biomaterials science

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Huimin Lin, Jie Yu, Xiang Gu, Shengfang Ge, Xianqun Fan
Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology. Clinical and translational medicine 11 (12) (2022)
Huixue Wang, Jie Yang, Hui Pan, Mei Chee Tai, Mohamed H Maher, Renbing Jia, Shengfang Ge, Linna Lu
Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and therapy 13 (2020)
Zhi Yang, P Li, Q Shang, Y Wang, J He, Shengfang Ge, Renbing Jia, Xianqun Fan
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression. Science advances 6 (48) (2020)
Jie Yu, Xian Jun Loh, Yifei Luo, Shengfang Ge, Xianqun Fan, Jing Ruan
Insights into the epigenetic effects of nanomaterials on cells. Biomaterials science 8 (3) (2019)